1. Home
  2. FCUV vs BIAF Comparison

FCUV vs BIAF Comparison

Compare FCUV & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Focus Universal Inc.

FCUV

Focus Universal Inc.

HOLD

Current Price

$5.06

Market Cap

4.9M

Sector

Industrials

ML Signal

HOLD

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$1.06

Market Cap

5.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCUV
BIAF
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.8M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
FCUV
BIAF
Price
$5.06
$1.06
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
30.6K
145.1K
Earning Date
03-26-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$387,457.00
$6,776,739.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.91
$0.69
52 Week High
$61.40
$46.53

Technical Indicators

Market Signals
Indicator
FCUV
BIAF
Relative Strength Index (RSI) 74.17 44.75
Support Level $4.91 $0.69
Resistance Level $6.19 $1.08
Average True Range (ATR) 0.86 0.15
MACD 0.57 0.00
Stochastic Oscillator 36.50 54.47

Price Performance

Historical Comparison
FCUV
BIAF

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: